News & Analysis - CNBC
-
Trump plans steep tariffs on generic drugs starting in 2028 to spur U.S. production
-
Wistron shares surge in Taiwan after opening of Texas AI superchip plant to supply Nvidia
-
Nike to cut off thousands of online distributors in China, restructure digital footprint
-
Super Micro surges 15% on new order and margin disclosure after SpaceX announcement
-
Goldman Sachs creates private markets platform as rich investors seek the next SpaceX and Stripe
-
These Japanese AI winners don’t make chips. They make toilets, glass fiber and seasoning
-
OpenAI appoints two new members to board of directors
-
The Fed rang the alarm about Anthropic's Mythos AI model — but had to go months without it
-
Capital One earnings were good enough but didn't answer the big question hanging over the stock
-
Jamie Dimon says markets underestimate risks and he wouldn't buy stocks or Treasurys at current prices
-
GM announces new gas-powered Cadillac vehicles amid EV pullback
-
Apple prepares a new way to buy iPhones. Plus, making sense of Google's new AI models
-
The FDA made a big reversal in its cyclosporiasis probe, but it still thinks iceberg lettuce is to blame
-
Sony’s 'ironic' PlayStation disc decision upends gamer conventions and threatens a $7 billion resale market
-
Wall Street can wait: Why one U.S. biotech firm is listing in Hong Kong first
-
IRS chief Frank Bisignano dismisses JPMorgan spying allegations
-
Japan exports and imports grow at fastest pace in June since November 2022, beating estimates
-
Prediction markets and their opponents are spending more to influence Congress in 2026
-
RFK Jr. says cyclospora outbreak is 'under control'
-
Mamdani says New York lacks authority to arrest Netanyahu, calls him ‘war criminal’